Erin Ohliger, MD, is a fellowship-trained hand and upper extremity surgeon who specializes in all conditions of the arm, including fractures, arthritis, tendon disorders, sports injuries, and nerve compression or damage. She is trained in arthroscopy, minimally invasive surgical approaches and microvascular surgery. Dr. Ohliger adopts a personal approach to each patient, taking time to understand them in order to develop a collaborative treatment plan that addresses their individual goals.
Dr. Ohliger completed her undergraduate education at Kent State University. She attended Northeast Ohio Medical University where she was inducted into the Alpha Omega Alpha Honor Medical Society. After completing her orthopedic residency at the Cleveland Clinic, she pursued subspecialty training in hand and upper extremity surgery at the prestigious Rothman Institute at Thomas Jefferson University in Philadelphia.
Dr. Ohliger is committed to providing compassionate, evidence-based care. She has numerous peer-reviewed publications on various orthopedic and upper extremity topics. She has presented her research at the American Society for Surgery of the Hand and the American Academy of Orthopaedic Surgeons. In her free time, she enjoys spending time with her family, hiking and exploring the outdoors. Dr. Ohliger is a third-generation Lorain County physician who looks forward to taking care of patients in the region that she calls home.
Fellowship | Hand and Upper Extremity Surgery
Hand and Upper Extremity Surgery - Rothman Orthopaedic Specialty Hospital (2022 - 2023)
Residency | Orthopaedic Surgery
Orthopaedic Surgery - Cleveland Clinic (2017 - 2022)
Northeast Ohio Medical University (NEOMED) (2017)
Kent State University (2013)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Erin Ohliger did not disclose any Outside Relationships with Industry.